Table 2 Prevalence (number and proportions) of the two groups of patients HFpEF and HFrEF reporting at least some problems (levels 2 or 3) for each dimension of EQ-5D at baseline and at follow up and changes between baseline and follow up
Number of patients reporting problems levels 2 and 3 | Change in numbers of patients reporting problems levels 2 and 3 | Percent change in numbers of patients reporting problems levels 2 and 3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
HFpEF > 50%, | HFrEF < 40% | EF > 50%, | EF < 40% | EF > 50%, | EF < 40% | |||||
Baseline % (n) | Follow up % (n) | p-value | Baseline % (n) | Follow up % (n) | p-value | |||||
Mobility | 51 (473) | 58 (540) | < 0.001 | 36 (1396) | 42 (1598) | < 0.001 | + 67 | + 202 | + 14% | + 14% |
Self-care | 13 (121) | 18 (163) | 0.001 | 9 (341) | 10 (402) | 0.003 | + 42 | + 61 | + 35% | + 18% |
Usual activities | 34 (320) | 41 (382) | < 0.001 | 31 (1203) | 29 (1120) | 0.013 | + 62 | - 83 | + 19% | - 7% |
Pain/discomfort | 55 (516) | 66 (618) | < 0.001 | 43 (1644) | 52 (1990) | < 0.001 | + 102 | + 346 | + 20% | + 21% |
Anxiety/depression | 44 (406) | 48 (444) | 0.025 | 40 (1525) | 39 (1505) | 0.550 | + 38 | - 20 | + 9,4% | - 1% |
EQ-5D Index (mean levels) | 0.71 | 0.67 | < 0.001 | 0.77 | 0.76 | 0.051 | ||||